Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Bill Haddad

1664 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Earnings
  • News

Owens-Corning Q2 EPS $3.83 Beats $3.32 Estimate, Sales $2.60B Beat $2.57B Estimate

By Bill Haddad
July 27, 6:07 AM
Owens-Corning (NYSE:OC) reported quarterly earnings of $3.83 per share which beat the analyst consensus estimate of $3.32 by 15.36 percent. This is a 47.31 percent increase over earnings of $2.60 per share from the same

OC

Read More
1 minute read
  • Earnings
  • News

Bunge Q2 EPS $2.97 Up From $2.61 YoY, Sales $17.93B Beat $16.81B Estimate

By Bill Haddad
July 27, 6:03 AM
Bunge (NYSE:BG) reported quarterly earnings of $2.97 per share. This is a 13.79 percent increase over earnings of $2.61 per share from the same period last year. The company reported quarterly sales of $17.93 billion

BG

Read More
1 minute read
  • Earnings
  • News

Hilton Worldwide Holdings Q2 EPS $1.29 Beats $1.04 Estimate, Sales $2.24B Beat $2.08B Estimate

By Bill Haddad
July 27, 6:01 AM
Hilton Worldwide Holdings (NYSE:HLT) reported quarterly earnings of $1.29 per share which beat the analyst consensus estimate of $1.04 by 24.04 percent. This is a 130.36 percent increase over earnings of $0.56 per share

HLT

Read More
1 minute read
  • Earnings
  • News

Premier Financial Q2 EPS $0.63 Misses $0.73 Estimate

By Bill Haddad
July 26, 4:28 PM
Premier Financial (NASDAQ:PFC) reported quarterly earnings of $0.63 per share which missed the analyst consensus estimate of $0.73 by 13.7 percent. This is a 25 percent decrease over earnings of $0.84 per share from the

PFC

Read More
1 minute read
  • General
  • Global
  • News
  • Politics

White House’s Kirby Says US Has Seen No Indication Of Delivery To Or Purchase Of Iranian Drones By The Russian Ministry Of Defense

By Bill Haddad
July 26, 3:13 PM
-Reuters

RSX

Read More
1 minute read
  • General
  • Global
  • News
  • Politics

White House’s Kirby Says Biden Has Not Yet Made A Decision Regarding Removal Of Tariffs On Chinese Goods

By Bill Haddad
July 26, 2:54 PM
-Reuters

FXI

Read More
1 minute read
  • General
  • Global
  • News
  • Politics

White House’s Kirby Says He Doubts Tariffs Will Be A Big Topic For Biden-Xi Call

By Bill Haddad
July 26, 2:45 PM
-Reuters

FXI

Read More
1 minute read
  • General
  • Global
  • News
  • Politics

White House Spokesman John Kirby Says Expected Call Between Biden And China’s Xi To Cover Range Of Issues, Including Taiwan, Ukraine And Managing US-China Competition

By Bill Haddad
July 26, 2:43 PM
-Reuters

FXI

Read More
1 minute read
  • General
  • Health Care
  • News

‘As of today, 1,092 people have tested positive for orthopoxvirus in NYC, which is presumed to be monkeypox.’ -NYC Healthy

By Bill Haddad
July 26, 2:16 PM
https://twitter.com/nycHealthy/status/1551994547760234498

AEMD

Read More
1 minute read
  • Biotech
  • General
  • Legal
  • News

Aurinia Pharmaceuticals Receives Notice Regarding USPTO Trial And Appeal Board Decision To Institute Trial On Inter Partes Review Filed By Sun Pharmaceuticals

By Bill Haddad
July 26, 2:03 PM
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) ("Aurinia" or the "Company") today received notice regarding the U.S. Patent Office (USPTO) Patent Trial and Appeal Board (PTAB) decision to institute trial

AUPH

Posts pagination

Previous 1 … 138 139 140 … 167 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service